Phase 3 Myocardial Injury Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
Colchicine in Patients at Cardiac Risk Undergoing Major Non-Cardiac Surgery
Cardiovascular DiseasesCardiovascular ComplicationMyocardial Injury+2 more
Cantonal Hospital of St. Gallen880 enrolled1 locationNCT06279000
Recruiting
Phase 3
Study of Intravenous TAD® 600 Mg/4 ML Solution for Injection to Evaluate Efficacy and Safety in Preventing Myocardial Injury in Patients with Pneumonia.
PneumoniaMyocardial Injury
Biomedica Foscama S.p.A. Industria Chimico-Farmaceutica178 enrolled7 locationsNCT06296212
Recruiting
Phase 3
Double blind, placebo controlled randomised trial assessing the efficacy of endothelin-1 receptor antagonism in the prevention of microvascular injury in patients with non-ST elevation acute coronary syndrome (NSTEACS) undergoing percutaneous coronary intervention: the ENDORA-PCI trial
Peri-procedural myocardial injury/infarctionNon-ST elevation acute coronary syndrome (NSTEACS)
Prince of Wales Hospital52 enrolled1 locationACTRN12615000709549